重症神经患者预后沟通的变异性:一项多中心混合方法预试验
这项多中心混合方法预试验对7个美国中心的39例重症神经患者、88名家属和27名临床医生之间的43次音频录制医患家庭会议进行了定性编码,归纳出4种预后沟通方式:权威型21%、信息型23%、建议型42%和回应型14%。校正前,预后沟通方式与中心、临床医生专业、患者年龄、诊断和会议时长相关;校正后仅临床医生专业(神经重症与非神经重症)独立预测沟通方式(p=0.027)。41%的患者发生了撤除生命维持治疗决策,建议型方式下最常见(56%),但预后沟通方式与撤除生命维持治疗无独立关联(p=0.198)。
要点
- 在7个美国中心43次医患家庭会议中,临床医生采用4种预后沟通方式:权威型21%、信息型23%、建议型42%、回应型14%。
- 校正后仅临床医生专业(神经重症 vs 非神经重症)独立预测预后沟通方式(p=0.027)。
- 撤除生命维持治疗决策发生在41%的患者中,建议型沟通方式下最常见(56%)。
- 预后沟通方式与撤除生命维持治疗无独立关联(p=0.198)。
- 作者认为,数据提示需要在重症神经患者中开展更大规模研究,以检验临床医生可变的预后沟通在撤除生命维持治疗决策中的作用。
适用人群与场景
- 美国7个中心的重症神经患者(CINPs),共39例,涉及88名家属和27名临床医生,分析了43次音频录制的医患家庭会议,会议中讨论了预后。
研究设计与关键结果
- 研究设计:多中心混合方法预试验,对43次音频录制的医患家庭会议进行定性编码(评分者间信度>80%),归纳出4种预后沟通方式:权威型21%(推荐治疗而不讨论价值观和偏好)、信息型23%(仅告知预后而无进一步讨论)、建议型42%(告知预后后讨论价值观和偏好)、回应型14%(先引出价值观和偏好再告知预后)。
- 校正前,预后沟通方式与中心(p<0.001)、临床医生专业(神经重症 vs 非神经重症;p=0.001)、患者年龄(p=0.08)、诊断(p=0.059)和会议时长(p=0.03)相关;校正后仅临床医生专业独立预测预后沟通方式(p=0.027)。
- 撤除生命维持治疗决策发生在41%的患者中,建议型沟通方式下最常见(56%);撤除生命维持治疗在老年患者(p=0.059)和经验更丰富的临床医生(p=0.07)中更可能发生;预后沟通方式与撤除生命维持治疗无独立关联(p=0.198)。
证据类型、等级与局限
- 证据类型:多中心混合方法预试验(可行性研究),样本量小(39例患者、43次会议),作者结论指出数据提示需要在重症神经患者中开展更大规模研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在多个ICU对重症神经患者的敏感医患家庭会议进行音频录制是可行的。
- 作者认为,临床医生的预后沟通方式高度可变,数据提示需要在重症神经患者中开展更大规模研究,以检验临床医生可变的预后沟通在撤除生命维持治疗决策中的作用。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Withdrawal-of-life-sustaining treatments (WOLST) rates vary widely among critically ill neurologic patients (CINPs) and cannot be solely attributed to patient and family characteristics. Research in general critical care has shown that clinicians prognosticate to families with high variability. Little is known about how clinicians disclose prognosis to families of CINPs, and whether any associations exist with WOLST.
OBJECTIVES: Primary: to demonstrate feasibility of audio-recording clinician-family meetings for CINPs at multiple centers and characterize how clinicians communicate prognosis during these meetings. Secondary: to explore associations of 1) clinician, family, or patient characteristics with clinicians' prognostication approaches and 2) prognostication approach and WOLST.
DESIGN SETTING AND PARTICIPANTS: Forty-three audio-recorded clinician-family meetings during which prognosis was discussed from seven U.S. centers for 39 CINPs with 88 family members and 27 clinicians.
MAIN OUTCOMES AND MEASURES: Two investigators qualitatively coded transcripts using inductive methods (inter-rater reliability > 80%) to characterize how clinicians prognosticate. We then applied univariate and multivariable multinomial and binomial logistic regression.
RESULTS: Clinicians used four distinct prognostication approaches: Authoritative (21%; recommending treatments without discussing values and preferences); Informational (23%; disclosing just the prognosis without further discussions); advisory (42%; disclosing prognosis followed by discussion of values and preferences); and responsive (14%; eliciting values and preferences, then disclosing prognosis). Before adjustment, prognostication approach was associated with center (p < 0.001), clinician specialty (neurointensivists vs non-neurointensivists; p = 0.001), patient age (p = 0.08), diagnosis (p = 0.059), and meeting length (p = 0.03). After adjustment, only clinician specialty independently predicted prognostication approach (p = 0.027). WOLST decisions occurred in 41% of patients and were most common under the advisory approach (56%). WOLST was more likely in older patients (p = 0.059) and with more experienced clinicians (p = 0.07). Prognostication approach was not independently associated with WOLST (p = 0.198).
CONCLUSIONS AND RELEVANCE: It is feasible to audio-record sensitive clinician-family meetings about CINPs in multiple ICUs. We found that clinicians prognosticate with high variability. Our data suggest that larger studies are warranted in CINPs to examine the role of clinicians' variable prognostication in WOLST decisions.
参考来源
- Ge C, Goss AL, Crawford S, et al. Variability of Prognostic Communication in Critically Ill Neurologic Patients: A Pilot Multicenter Mixed-Methods Study. Crit Care Explor. 2022. PMID: 35224505. doi:10.1097/CCE.0000000000000640
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。